IBDEI1BO ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22480,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,22480,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,22481,0)
 ;;=C79.71^^87^981^151
 ;;^UTILITY(U,$J,358.3,22481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22481,1,3,0)
 ;;=3^Malig Neop Right Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,22481,1,4,0)
 ;;=4^C79.71
 ;;^UTILITY(U,$J,358.3,22481,2)
 ;;=^5001356
 ;;^UTILITY(U,$J,358.3,22482,0)
 ;;=C78.01^^87^981^155
 ;;^UTILITY(U,$J,358.3,22482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22482,1,3,0)
 ;;=3^Malig Neop Right Lung,Secondary
 ;;^UTILITY(U,$J,358.3,22482,1,4,0)
 ;;=4^C78.01
 ;;^UTILITY(U,$J,358.3,22482,2)
 ;;=^5001335
 ;;^UTILITY(U,$J,358.3,22483,0)
 ;;=C79.70^^87^981^106
 ;;^UTILITY(U,$J,358.3,22483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22483,1,3,0)
 ;;=3^Malig Neop Adrenal Gland Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,22483,1,4,0)
 ;;=4^C79.70
 ;;^UTILITY(U,$J,358.3,22483,2)
 ;;=^5001355
 ;;^UTILITY(U,$J,358.3,22484,0)
 ;;=C78.00^^87^981^139
 ;;^UTILITY(U,$J,358.3,22484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22484,1,3,0)
 ;;=3^Malig Neop Lung Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,22484,1,4,0)
 ;;=4^C78.00
 ;;^UTILITY(U,$J,358.3,22484,2)
 ;;=^5001334
 ;;^UTILITY(U,$J,358.3,22485,0)
 ;;=D57.1^^87^981^182
 ;;^UTILITY(U,$J,358.3,22485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22485,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,22485,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,22485,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,22486,0)
 ;;=D75.1^^87^981^180
 ;;^UTILITY(U,$J,358.3,22486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22486,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,22486,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,22486,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,22487,0)
 ;;=C90.30^^87^981^183
 ;;^UTILITY(U,$J,358.3,22487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22487,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,22487,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,22487,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,22488,0)
 ;;=D56.3^^87^981^184
 ;;^UTILITY(U,$J,358.3,22488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22488,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,22488,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,22488,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,22489,0)
 ;;=D56.9^^87^981^185
 ;;^UTILITY(U,$J,358.3,22489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22489,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,22489,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,22489,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,22490,0)
 ;;=M31.1^^87^981^187
 ;;^UTILITY(U,$J,358.3,22490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22490,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,22490,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,22490,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,22491,0)
 ;;=D51.2^^87^981^188
 ;;^UTILITY(U,$J,358.3,22491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22491,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,22491,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,22491,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,22492,0)
 ;;=D05.92^^87^981^35
 ;;^UTILITY(U,$J,358.3,22492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22492,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,22492,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,22492,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,22493,0)
 ;;=D05.91^^87^981^37
 ;;^UTILITY(U,$J,358.3,22493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22493,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,22493,1,4,0)
 ;;=4^D05.91
